CD4 and colitis: In contrast to the effect of AICAR on colitis LP CD4+ T cells, the addition of C.C. increased the frequency of IFN-γ-producing colitis LP CD4+ T cells as well as that of IL-17A-producing LP CD4+ T cells (Fig. 3B,C).